i
Visceral Leishmaniasis Treatment, Europe
-
Dec 2003
Source: Emerg Infect Dis. 9(12):1617-1620. -
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:First-line drug treatment was recorded in 573 immunocompetent patients with visceral leishmaniasis in Europe. In the past 12 years, the proportion of antimonial treatments decreased from 100% to 2.8%, while the proportion of amphotericin B treatments increased from 0% to 97.2%. The countrywide change in therapy is a response to both disease reemergence and increasing antimonial failure.
-
Subjects:
-
Document Type:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
-
gif jpeg gif jpeg txt txt
Details:
Supporting Files
More +